🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07295925
Starting soon Observational

Risk Factors for Postoperative Fever and Sepsis Following Retrograde Intrarenal Surgery

NCT07295925 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-01
Last updated
2025-12-22

Condition(s) studied

Urolithiasis

Study summary

This prospective clinical study aims to evaluate preoperative, intraoperative, and postoperative characteristics of patients undergoing retrograde intrarenal surgery (RIRS) for urinary stone disease. A total of approximately 250 patients will be assessed to identify clinical, laboratory, and operative factors associated with postoperative fever and sepsis. By systematically collecting and analyzing perioperative data, the study seeks to determine independent predictors that may support improved risk stratification and patient safety in endourological practice.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 18 years or older. * Patients scheduled to undergo retrograde intrarenal surgery (RIRS) for the treatment of renal or ureteral stones. * Completion of routine preoperative and postoperative clinical assessments required for RIRS. * Ability to provide informed consent. Exclusion Criteria: * Terminal-stage malignancy. * Bleeding diathesis or known immunodeficiency. * Active infectious condition at the time of surgery. * Patients deemed unsuitable for anesthesia or surgery by the Department of Anesthesiology. * Pregnancy. * Contraindications to RIRS or inability to complete required perioperative evaluations.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Erciyes University Faculty of Medicine, Department of Urology Kayseri Melikgazi

More TC Erciyes University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07295925 on ClinicalTrials.gov ↗ ← All trials in Turkey